The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.11%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.91%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.89%. September E-mini...
/Insulet%20Corporation%20insulin%20monitor-by%20Maria%20Wan%20via%20Shutterstock.jpg)
Insulet has outperformed the Medical Devices industry over the past year, and analysts are highly optimistic about the stock’s prospects.
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TNDM),(NYSE:NVO),(NASDAQ:PODD),(NYSE:MDT) EQNX::TICKER_END
/Dexcom%20Inc%20HQ-by%20JHVEPhoto%20via%20Shutterstock.jpg)
DexCom has underperformed the Health Care sector over the past year, but analysts are highly optimistic about the stock’s prospects.
Three med-tech stocks, TransMedics, Insulet, and GRAIL, are outperforming the market and their sector while forming bullish technical patterns.
/Insulet%20Corporation%20logo%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)
Insulet has significantly outpaced the broader market over the past year, and analysts remain bullish on the stock’s prospects.
Insulet's earnings and upgraded guidance recently propelled its stock to S&P 500 leadership, showcasing strong execution in the diabetes care market.
U.S. stocks rallied after China and the United States announced a 90-day truce in their trade war